Home › Spinal Cord Injuries › NCT07870642

Vibratory Genital Nerve Stimulation (vGNS) to Treat Female Sexual Dysfunction (FSD) After Spinal Cord Injury (SCI)

Advancing Sexual Health in Spinal Cord Injury: Evaluation of Vibratory Genital Nerve Stimulation

Who can join

Ages 18 to 65 · Women

Inclusion Criteria:

* Be cisgender women aged 18 to 65 years (current study is scoped specifically to cisgender female anatomy)
* Have a chronic (\> 1 year) spinal cord injury
* Self-report impaired sexual function (e.g., arousal, lubrication, orgasm)
* Be sexually active or report a desire for sexual activity
* Be able to place and operate the Lioness device independently
* Be able to provide informed consent and participate in study procedures

Exclusion Criteria:

* Are currently pregnant or attempting to become pregnant
* Have a history of autonomic dysreflexia (AD) triggered by sexual activity or genital stimulation
* Have undergone pelvic reconstructive surgery
* Report being unable to independently position and operate the Lioness device due to motor or anatomical limitations
* Have a recent history of urinary tract infection, vaginal infection, or active genital skin condition within the last 3 months
* Have implanted medical devices or cardiovascular instability that contraindicates vibratory stimulation (e.g., pacemaker)
* Are currently taking medications that may influence sexual arousal response in the opinion of the investigator

About the study

The goal of this clinical trial is to learn if vibratory genital nerve stimulation (vGNS) can improve sexual function in women with spinal cord injury. The main question it aims to answer is:

Does acute vGNS increase genital blood flow during a standardized sexual arousal assessment, as measured by laser speckle contrast imaging?

Participants will:

Complete a baseline in-clinic visit including two sexual arousal assessments with a vGNS session in between, while genital blood flow is measured using a non-invasive imaging device

Use a vibration device at home twice weekly for 12 weeks

Complete questionnaires about sexual function at baseline, during the home phase, and at a 12-week follow-up visit

Attend a follow-up in-clinic visit repeating the baseline assessments

What is being tested

• Vibratory genital nerve stimulation (device)

Sponsor: Samuel Cramer · Participants: 20 · Started: 2026-09

Contact the study team

• Study Coordinator · Phone: 612-873-9113

Official record on ClinicalTrials.gov — NCT07870642

Locations in the U.S.

Conditions

• Spinal Cord Injuries

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.